tiprankstipranks
Cardinal Health (CAH)
NYSE:CAH
US Market
Want to see CAH full AI Analyst Report?

Cardinal Health (CAH) Earnings Dates, Call Summary & Reports

2,482 Followers

Earnings Data

Report Date
Aug 18, 2026
Before Open (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
2.4
Last Year’s EPS
2.08
Same Quarter Last Year
Based on 13 Analysts Ratings

Earnings Call Summary

Q3 2026
Earnings Call Date:Apr 30, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call highlighted broad-based operational strength: solid top-line growth, outsized EPS improvement, robust free cash flow generation, meaningful outperformance in Specialty and other growth businesses, and a raised, narrowed FY26 outlook. Challenges noted include a $184M goodwill impairment for Navista, tariff-related pressure in the GMPD business with uncertain refunds (paid ~ $200M to date), higher headline SG&A and rising interest costs, and revenue mix headwinds from IRA/WAC adjustments and GLP-1 moderation. On balance the company emphasized durable fundamentals, disciplined capital deployment (including $1B of buybacks), successful integration of acquisitions and confidence in long-term targets.
Company Guidance
Cardinal raised its fiscal 2026 guidance, boosting non‑GAAP EPS to $10.70–$10.80 (a ~$0.50 midpoint increase, implying ~30–31% annual EPS growth), and increasing adjusted free cash flow to $3.3–$3.7B (from $3.0–$3.5B); it also lowered full‑year non‑GAAP effective tax rate to ~19% (from 21–23%), updated interest & other to ~$340M (from $325M), and now models ~237M weighted average shares. Segment guidance: Pharma revenue is expected at the low end of the prior 15–17% range with segment profit growth raised and narrowed to 22–23% (vs. 20–22% prior); GMPD revenue reiterated at 1–3% with profit guidance of $150M; Other growth businesses revenue guidance remains 26–28% while profit growth was lifted to 36–38% (from 33–35%). Management said the hike reflects ~ $0.13 of operational strength (Pharma and Other) with the remainder below the line, and pointed to Q3 momentum (Q3 non‑GAAP EPS $3.17, +35%; total revenue $61B, +11%; gross profit $2.5B, +18%; enterprise operating earnings $956M, +18%; Q3 adjusted FCF $1.7B; cash ≈$4B) as the basis for confidence.
Top-line and EPS Growth
Total company revenue rose 11% year-over-year to $61.0 billion in Q3; gross profit increased 18% to $2.5 billion; enterprise operating earnings grew 18% to $956 million; third quarter non-GAAP EPS was $3.17, up 35%.
Pharmaceutical & Specialty Strength
Pharma segment revenue grew 11% to $56.1 billion and segment profit increased 18% to $784 million. Specialty delivered robust growth (over 20% in Q3), GLP-1 revenue grew over 30% (adding ~6 percentage points to revenue growth), and management reiterated expectation for Specialty revenue to exceed $50 billion in fiscal 2026.
Other Growth Businesses Driving Outperformance
At-Home Solutions, Nuclear & Precision Health Solutions and OptiFreight grew revenue 31% to $1.7 billion and segment profit 34% to $179 million. Theranostics revenue grew >30%, OptiFreight revenue nearly 20%, and the ADS integration into at-Home Solutions is progressing with meaningful patient and employee onboarding.
Strong Cash Flow and Capital Allocation
Generated $1.7 billion of adjusted free cash flow in the quarter; ended the quarter with nearly $4.0 billion cash. Raised full-year adjusted free cash flow guidance to $3.3–$3.7 billion (from $3.0–$3.5B). Returned capital via share repurchases of $1.0 billion year-to-date (including an additional $250 million ASR), prepaid $100 million on term loan and reduced Moody's-adjusted leverage to ~3.0x.
Raised and Narrowed Fiscal Year Guidance
Raised full-year fiscal 2026 non-GAAP EPS guidance to $10.70–$10.80 (≈$0.50 increase at midpoint; implied annual EPS growth 30–31%). Increased Pharma segment profit growth outlook to 22–23% (from 20–22%) and raised Other growth businesses profit guidance to 36–38% (from 33–35%).
Operational Execution & Service Levels
Management highlighted record-high service levels, successful integration of recent acquisitions (e.g., ADS, onboarding of Solaris/GIA distribution volumes in Q4) and effective operational responses to winter storms and supply chain complexity.

Cardinal Health (CAH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CAH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 18, 2026
2026 (Q4)
2.40 / -
2.08
Apr 30, 2026
2026 (Q3)
2.79 / 3.17
2.3534.89% (+0.82)
Feb 05, 2026
2026 (Q2)
2.34 / 2.63
1.9336.27% (+0.70)
Oct 30, 2025
2026 (Q1)
2.18 / 2.55
1.8835.64% (+0.67)
Aug 12, 2025
2025 (Q4)
2.04 / 2.08
1.8413.04% (+0.24)
May 01, 2025
2025 (Q3)
2.17 / 2.35
2.0812.98% (+0.27)
Jan 30, 2025
2025 (Q2)
1.78 / 1.93
1.826.04% (+0.11)
Nov 01, 2024
2025 (Q1)
1.62 / 1.88
1.738.67% (+0.15)
Aug 14, 2024
2024 (Q4)
1.73 / 1.84
1.5518.71% (+0.29)
May 02, 2024
2024 (Q3)
1.95 / 2.08
1.7419.54% (+0.34)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CAH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 30, 2026
$202.82$192.88-4.90%
Feb 05, 2026
$206.35$226.63+9.83%
Oct 30, 2025
$163.66$188.91+15.43%
Aug 12, 2025
$156.38$145.11-7.21%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cardinal Health (CAH) report earnings?
Cardinal Health (CAH) is schdueled to report earning on Aug 18, 2026, Before Open (Confirmed).
    What is Cardinal Health (CAH) earnings time?
    Cardinal Health (CAH) earnings time is at Aug 18, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CAH EPS forecast?
          CAH EPS forecast for the fiscal quarter 2026 (Q4) is 2.4.

            Cardinal Health (CAH) Earnings News

            CAH Earnings: Cardinal Rises on Raised Outlook & Robust Q4 Results
            Premium
            Market News
            CAH Earnings: Cardinal Rises on Raised Outlook & Robust Q4 Results
            2y ago